Valganciclovir Therapy Prevents Human Cytomegalovirus Reactivation in Glioblastoma Patients Undergoing Radiochemotherapy and Extends Time to Tumor Progression.

Pantalone MR, Stragliotto G, Martin-Almazan N, Peredo-Harvey I, Jimenez-Macias JL, Rahbar A, Lawler S, Bartek J, Söderberg-Naucler C

Open source

DOI
10.3390/cancers18101575
Published
2026 May 12
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18101575,
  title = {Valganciclovir Therapy Prevents Human Cytomegalovirus Reactivation in Glioblastoma Patients Undergoing Radiochemotherapy and Extends Time to Tumor Progression.},
  author = {Pantalone MR and Stragliotto G and Martin-Almazan N and Peredo-Harvey I and Jimenez-Macias JL and Rahbar A and Lawler S and Bartek J and Söderberg-Naucler C},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18101575},
  url = {https://doi.org/10.3390/cancers18101575}
}

RIS

TY  - JOUR
TI  - Valganciclovir Therapy Prevents Human Cytomegalovirus Reactivation in Glioblastoma Patients Undergoing Radiochemotherapy and Extends Time to Tumor Progression.
AU  - Pantalone MR
AU  - Stragliotto G
AU  - Martin-Almazan N
AU  - Peredo-Harvey I
AU  - Jimenez-Macias JL
AU  - Rahbar A
AU  - Lawler S
AU  - Bartek J
AU  - Söderberg-Naucler C
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18101575
UR  - https://doi.org/10.3390/cancers18101575
ER  - 

APA

MR, P., G, S., N, M., I, P., JL, J., A, R., S, L., J, B., & C, S. (2026). Valganciclovir Therapy Prevents Human Cytomegalovirus Reactivation in Glioblastoma Patients Undergoing Radiochemotherapy and Extends Time to Tumor Progression.. Cancers. https://doi.org/10.3390/cancers18101575

Source records